CDK7 and non-small cell lung carcinoma: Given promising previous findings of in vitro studies with CDK7 inhibitors on NSCLC cells together with our findings and assuming that protein expression of CDK7 in the large cohort of NSCLC might indicate sensitivity to CDK7 inhibition, one could suggest that CDK7 might serve as a novel prognostic biomarker and additionally as therapeutic target.